2017
Congenital Extrahepatic Portosystemic Shunt (Abernethy Malformation Type Ib) With Associated Hepatocellular Carcinoma
Benedict M, Rodriguez-Davalos M, Emre S, Walther Z, Morotti R. Congenital Extrahepatic Portosystemic Shunt (Abernethy Malformation Type Ib) With Associated Hepatocellular Carcinoma. Pediatric And Developmental Pathology 2017, 20: 354-362. PMID: 28727971, DOI: 10.1177/1093526616686458.Peer-Reviewed Case Reports and Technical NotesConceptsAbernethy malformationCongenital portosystemic shuntsHepatocellular carcinomaPortosystemic shuntPortal veinVena cavaCongenital absenceCongenital extrahepatic portosystemic shuntAssociated Hepatocellular CarcinomaSplanchnic venous systemNodular regenerative hyperplasiaExtrahepatic portosystemic shuntSmall hepatocellular carcinomaFocal nodular hyperplasiaRegenerative hyperplasiaClinical manifestationsImmunohistochemical characteristicsIntrahepatic shuntsLiver adenomasTypical presentationPortal bloodNodular hyperplasiaVenous systemComplete diversionResult of malformation
2011
Molecular Pathology of Hepatic Neoplasms: Classification and Clinical Significance
Walther Z, Jain D. Molecular Pathology of Hepatic Neoplasms: Classification and Clinical Significance. Pathology Research International 2011, 2011: 403929. PMID: 21559202, PMCID: PMC3090128, DOI: 10.4061/2011/403929.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsFocal nodular hyperplasiaHepatocellular carcinomaHepatocellular adenomaHepatic neoplasmsLiver cancerDysplastic nodulesMolecular classificationPrimary hepatic tumorsEarly hepatocellular carcinomaNovel therapeutic targetProgenitor cell phenotypeCommon malignancyPrognostic implicationsHCC-CCHepatic tumorsNodular hyperplasiaClinical significanceMolecular subtypesTherapeutic targetClinical practiceHepatic neoplasiaDistinct subtypesPatient careTumor phenotypeMolecular pathology